Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lisata Therapeutics Inc LSTA

Healthcare Biotechnology
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to... see more

Recent & Breaking News (NDAQ:LSTA)

Caladrius Biosciences to Present at the 2018 BIO CEO & Investor Conference

GlobeNewswire February 7, 2018

Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

GlobeNewswire January 18, 2018

Caladrius Biosciences to Present at the 10th Annual LD Micro Main Event

GlobeNewswire December 1, 2017

Caladrius Biosciences Reports 2017 Third Quarter Results

GlobeNewswire November 9, 2017

Caladrius Biosciences, Inc. to Host Earnings Call

Accesswire November 9, 2017

Caladrius Biosciences to Host 2017 Third Quarter Business Update Conference Call on November 9, 2017 at 4:30 p.m. Eastern Time

GlobeNewswire November 2, 2017

Caladrius Biosciences to Participate at Upcoming November Conferences

GlobeNewswire November 1, 2017

Caladrius Biosciences Awarded Approximately $2 Million NIH Grant to Support Clinical Study of CLBS14 in Patients with Coronary Microvascular Dysfunction

GlobeNewswire October 2, 2017

Caladrius Biosciences to Participate at the 2017 Cell & Gene Meeting on the Mesa

GlobeNewswire September 28, 2017

Smart Medical Device Could Save Millions of Lives

PR Newswire September 13, 2017

Caladrius Biosciences to Participate at Upcoming September Conferences

GlobeNewswire September 7, 2017

Caladrius Biosciences Announces Enrollment of the 70th Subject in the Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

GlobeNewswire September 5, 2017

Investor Network: Caladrius Biosciences, Inc. to Host Earnings Call

Accesswire August 10, 2017

Caladrius Biosciences to Host 2017 Second Quarter Results Conference Call on August 10, 2017 at 4:30 p.m. Eastern Time

GlobeNewswire August 3, 2017

Caladrius Biosciences Announces that 50% of Subjects Have Been Treated in the Phase 2 Clinical Trial of CLBS03 for Type 1 Diabetes

GlobeNewswire July 19, 2017

Caladrius Biosciences Joins Russell Microcap® Index

GlobeNewswire June 26, 2017

Invetech and Caladrius Biosciences Receive 2017 Good Design Award® for Design of a Counterflow Centrifuge Device for use in the Development of Cell Therapies

PR Newswire June 14, 2017

Caladrius Biosciences to Participate at Upcoming June Conferences

GlobeNewswire June 1, 2017

Caladrius Biosciences Closes the Sale of its Remaining Interest in PCT to Hitachi Chemical for $75 Million

GlobeNewswire May 18, 2017

Caladrius Biosciences Announces 2017 First Quarter Financial Results

GlobeNewswire May 15, 2017